Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Allergy Asthma Proc ; 41(2): 120-125, 2020 03 01.
Artigo em Inglês | MEDLINE | ID: mdl-32122448

RESUMO

Background: Data are lacking with concern to the prevalence and management of aspirin (ASA) hypersensitivity. Objective: To study the prevalence, different types of reactions, and implications for clinical management of ASA hypersensitivity in a cardiology practice. Methods: We conducted an electronic medical record review of 11,375 individuals, 5052 (44%) in the ambulatory setting, and 6323 (56%) admitted for percutaneous coronary intervention (PCI), from January 2012 to December 2013. Results: The prevalence of ASA hypersensitivity was 1.88% (n = 214). Skin reactions were the most common (40 [19%]), followed by angioedema (10 [4.6%]), respiratory (9 [4.2%]), and anaphylaxis (6 [2.8%]). No records were found for 74 patients (34.5%), and 69 patients (32.2%) were mistakenly labeled as allergic for having gastrointestinal symptoms. Of the 214 patients who had documented ASA hypersensitivity, 108 individuals (50.46%) had coronary artery disease. The medications at discharge were the following: ASA (30 [14%]), thienopyridine (48 [22%]), a combination of ASA and thienopyridine (13 [6%]), anticoagulation only (26 [12%]), and no antiplatelet (97 [43%]). Conclusion: ASA hypersensitivity is often not documented correctly or is often misdiagnosed or not appropriately managed. There is a need for improved management of ASA hypersensitivity, including appropriate referral for ASA desensitization and combating unnecessary avoidance in patients with intolerance due to adverse effects.


Assuntos
Alérgenos/efeitos adversos , Aspirina/efeitos adversos , Doença das Coronárias/epidemiologia , Hipersensibilidade a Drogas/epidemiologia , Intervenção Coronária Percutânea , Adulto , Idoso , Idoso de 80 Anos ou mais , Alérgenos/imunologia , Aspirina/uso terapêutico , Doença das Coronárias/diagnóstico , Erros de Diagnóstico/prevenção & controle , Hipersensibilidade a Drogas/diagnóstico , Registros Eletrônicos de Saúde , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Prevalência , Estudos Retrospectivos , Estados Unidos/epidemiologia , Adulto Jovem
2.
Artigo em Inglês | MEDLINE | ID: mdl-27124164

RESUMO

A case is presented of significant reversible ST elevation occurring during treadmill testing, and the coronary anatomy and subsequent course are described, indicating that ischemia is a potential cause of this electrocardiographic finding.

3.
Artigo em Inglês | MEDLINE | ID: mdl-25432650

RESUMO

INTRODUCTION: Cardiac amyloidosis is the most common cause of infiltrative cardiomyopathy and is associated with a poor prognosis. Transthyretin cardiac amyloidosis, particularly the type caused by the mutation that replaces the amino acid valine with the amino acid isoleucine at position 122 (Val122Ile), is most common among African- Americans above 65 years of age. Evidence suggests that this mutation is an important, though under-diagnosed, cause of heart failure in this population. CASE PRESENTATION: A 74-year-old African American male with a diagnosis of non-ischemic cardiomyopathy for several years, presented with gradually worsening dyspnea on exertion and lower extremity edema. There is no known cardiac disease in his family. An echocardiogram was done showing a decrease in ejection fraction to 30% from 45% in the span of a year. An endomyocardial biopsy analysis identified transthyretin amyloid with the Val122Ile mutation, confirming the diagnosis of familial transthyretin cardiomyopathy. DISCUSSION: Systemic amyloidosis is a group of diseases caused by the deposition of an abnormally folded, insoluble protein that can accumulate in multiple organs causing progressive and irreversible dysfunction. The mutations that most commonly induce variant transthyretin cardiac amyloidosis are Val122Ile, Val30Met and Thr60Ala. The Val122Ile mutation has been found to be present in 3-4% of the African American/Caribbean population. CONCLUSIONS: Familial amyloid cardiomyopathy is an uncommonly recognized cause of heart failure in the population, and patients may wait several years before accurate diagnosis, risking additional significant irreversible deterioration. Patients that meet the high-risk profile criteria - male gender, age 65 years and older, heart failure symptoms, symmetric left ventricular (LV) hypertrophy, and moderately depressed LV function - should likely undergo additional testing for cardiac amyloidosis.

4.
Artigo em Inglês | MEDLINE | ID: mdl-24392217

RESUMO

A 37-year-old female presented to the hospital with erythema migrans and fatigue developed hypotension and variable episodes of AV block, including both Mobitz I and complete AV block. She was treated with IV antibiotics and her arrhythmia resolved within 24 hours without any further intervention.

5.
Artigo em Inglês | MEDLINE | ID: mdl-23882361

RESUMO

Beat-to-beat variations in QRS amplitude or axis may be caused by several conditions.

6.
Artigo em Inglês | MEDLINE | ID: mdl-23882365

RESUMO

Disappearance of a delta wave in a patient with pre-excitation is demonstrated following successful ablation.

7.
Artigo em Inglês | MEDLINE | ID: mdl-23882376

RESUMO

Presenting electrocardiograms of intermittent left bundle branch block in a 60-year-old female.

8.
Artigo em Inglês | MEDLINE | ID: mdl-23882386

RESUMO

A case of a 71-year-old male with congenital complete heart block is discussed. Patient remained asymptomatic with stable electrocardiograms.

9.
Artigo em Inglês | MEDLINE | ID: mdl-23882338

RESUMO

A case is presented of a man with a life-threatening tachyarrhythmia precipitated by ingested substances.

10.
Artigo em Inglês | MEDLINE | ID: mdl-25846357
12.
Artigo em Inglês | MEDLINE | ID: mdl-23882323
13.
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA